Liquid Biopsy
•23 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (23)
| Company | Market Cap | Price |
|---|---|---|
|
TMO
Thermo Fisher Scientific Inc.
Thermo Fisher supports liquid biopsy workflows and NGS-based diagnostics through its assay and instrumentation platforms.
|
$214.25B |
$567.41
+2.01%
|
|
NTRA
Natera, Inc.
Natera's Signatera MRD and Signatera Genome tests are liquid biopsy assays using cfDNA to detect minimal residual disease in cancer, a core liquid biopsy product.
|
$27.16B |
$198.94
+2.96%
|
|
LH
Labcorp Holdings Inc.
Labcorp offers liquid biopsy tests (e.g., MRD portfolios) as part of its oncology testing portfolio.
|
$21.10B |
$253.95
+0.64%
|
|
EXAS
Exact Sciences Corporation
Exact Sciences’ pipeline includes blood-based cancer diagnostics (liquid biopsy) such as Oncodetect MRD and blood-based CRC test programs, making Liquid Biopsy a core product category.
|
$12.20B |
$64.69
+2.33%
|
|
GH
Guardant Health, Inc.
Core product category: Guardant Health's liquid biopsy tests (Guardant360 Liquid/Tissue) are the primary offerings.
|
$11.60B |
$93.05
+0.69%
|
|
QGEN
Qiagen N.V.
QIAGEN is a leader in liquid biopsy sample preparation (ctDNA, cfDNA, exosomes), a core growth pillar.
|
$10.49B |
$46.85
+1.13%
|
|
GRAL
GRAIL, Inc.
Galleri is a liquid biopsy-based multi-cancer early detection test using cfDNA methylation, the core product.
|
$3.31B |
$91.90
+0.82%
|
|
VCYT
Veracyte, Inc.
The company offers MRD and other liquid biopsy tests, placing it in the liquid biopsy space.
|
$2.83B |
$36.10
+2.19%
|
|
NEO
NeoGenomics, Inc.
RaDaR liquid biopsy and PanTracer products are liquid biopsy diagnostic platforms.
|
$1.26B |
$9.78
+0.88%
|
|
PSNL
Personalis, Inc.
NeXT Personal is a tumor-informed liquid biopsy-based MRD test, central to PSNL's offerings.
|
$851.45M |
$9.61
+1.05%
|
|
CDNA
CareDx, Inc
Uses Liquid Biopsy approaches (dd-cfDNA) to monitor organ health and rejection in the transplant setting.
|
$835.21M |
$15.02
+3.80%
|
|
MYGN
Myriad Genetics, Inc.
MRD and liquid-biopsy–related testing, including Precise MRD/test for minimal residual disease.
|
$741.11M |
$8.04
+1.07%
|
|
SOPH
SOPHiA GENETICS S.A.
Liquid Biopsy: MSK-ACCESS application and liquid biopsy analytics integrated into the platform.
|
$332.19M |
$4.95
-4.62%
|
|
OSUR
OraSure Technologies, Inc.
Innovation pipeline includes blood proteomics and molecular diagnostics with liquid biopsy applications (CT/NG, Alzheimer's, etc.).
|
$204.95M |
$2.75
+1.67%
|
|
PRE
Prenetics Global Limited
Insighta's FRAGMA liquid biopsy enables multi-cancer early detection.
|
$181.14M |
$14.76
+4.31%
|
|
BNR
Burning Rock Biotech Limited
Burning Rock's brPROPHET MRD and MCED products are ctDNA-based diagnostics delivered as a liquid biopsy test.
|
$138.94M |
$13.56
+9.44%
|
|
BDSX
Biodesix, Inc.
Biodesix's Nodify and VeriStrat are blood-based diagnostic tests, i.e., liquid biopsy products.
|
$50.05M |
$6.98
+6.24%
|
|
VNRX
VolitionRx Limited
VolitionRx's Nu.Q platform enables liquid biopsy cancer diagnostics by detecting nucleosome/epigenetic biomarkers in blood.
|
$44.71M |
$0.43
-1.68%
|
|
MDXH
MDxHealth S.A.
MDxHealth's portfolio includes liquid-based diagnostic tests (Select mdx, Resolve mdx, ExoDx) that fit the Liquid Biopsy category.
|
$13.43M |
$4.92
+0.72%
|
|
BGLC
BioNexus Gene Lab Corp.
VitaGuard MRD is a tumor-naïve liquid biopsy platform used in BGLC's MRNA Scientific diagnostics, defining a liquid biopsy product category.
|
$9.74M |
$5.38
+3.66%
|
|
TRIB
Trinity Biotech plc
Pursues oncology diagnostics in a liquid-biopsy-like workflow (epigenetic tests for cancer), expanding the diagnostic pipeline.
|
$7.67M |
$1.02
+2.00%
|
|
PAVM
PAVmed Inc.
EsoGuard's DNA-based biomarker testing aligns with the Liquid Biopsy investable theme as a non-invasive cancer detection modality.
|
$7.56M |
$0.43
+0.62%
|
|
MYNZ
Mainz Biomed B.V.
PancAlert is a blood-based diagnostic test using biomarker panels (liquid biopsy) to detect pancreatic cancer, fitting the Liquid Biopsy investable theme.
|
$946703 |
$1.48
-1.67%
|
Loading company comparison...
Loading industry trends...
Loading research report...
